CLX Medical, Inc. Announces Agreement to License Additional Point-of-Care Diagnostic Testing Devices and the Outcome of the HandiLab-C Chlamydia Laboratory Study

MURRIETA, CA--(Marketwire - October 15, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today announced a letter of intent to license additional medical diagnostic testing devices from Intellect Holdings, Ltd., research and development company focusing on the development of innovative products for the healthcare industry.
MORE ON THIS TOPIC